Header Logo

Connection

Jonathan Gerber to Neoplastic Stem Cells

This is a "connection" page, showing publications Jonathan Gerber has written about Neoplastic Stem Cells.
Connection Strength

0.885
  1. Gerber JM, Gucwa JL, Esopi D, Gurel M, Haffner MC, Vala M, Nelson WG, Jones RJ, Yegnasubramanian S. Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations. Oncotarget. 2013 May; 4(5):715-28.
    View in: PubMed
    Score: 0.373
  2. Gerber JM, Smith BD, Ngwang B, Zhang H, Vala MS, Morsberger L, Galkin S, Collector MI, Perkins B, Levis MJ, Griffin CA, Sharkis SJ, Borowitz MJ, Karp JE, Jones RJ. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood. 2012 Apr 12; 119(15):3571-7.
    View in: PubMed
    Score: 0.341
  3. Ghiaur G, Gerber JM, Matsui W, Jones RJ. Cancer stem cells: relevance to clinical transplantation. Curr Opin Oncol. 2012 Mar; 24(2):170-5.
    View in: PubMed
    Score: 0.086
  4. Ghiaur G, Gerber J, Jones RJ. Concise review: Cancer stem cells and minimal residual disease. Stem Cells. 2012 Jan; 30(1):89-93.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.